Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues.

[1]  W. Sluiter,et al.  Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients , 1998, Diabetologia.

[2]  B. Sobel,et al.  Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. , 1996, Circulation.

[3]  S. Yamashita,et al.  Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  P. Morange,et al.  Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease , 1997, Diabetes.

[5]  J. Auwerx,et al.  Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM Patients , 1997, Diabetes.

[6]  M. Paul,et al.  Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. , 1993, The Journal of clinical investigation.

[7]  K. Cianflone,et al.  Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. , 1994, Biochemistry.

[8]  Johan Auwerx,et al.  Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects , 1998, Diabetes.

[9]  G. Ailhaud,et al.  Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells , 1996, FEBS letters.

[10]  A. Tall,et al.  Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. , 1998, Annual review of nutrition.

[11]  P. B. Jensen,et al.  Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  K. Cianflone,et al.  The adipocyte, fatty acid trapping, and atherogenesis. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[14]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[15]  W. Sluiter,et al.  Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism , 1994, European journal of clinical investigation.

[16]  S. Yamashita,et al.  Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.

[17]  P. Sutcliffe.  The Oxford University Press , 2000 .

[18]  R. McPherson,et al.  Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. , 1998, Atherosclerosis.

[19]  S. O’Rahilly,et al.  Depot- and Sex-Specific Differences in Human Leptin mRNA Expression: Implications for the Control of Regional Fat Distribution , 1997, Diabetes.

[20]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[21]  M. McDonnell,et al.  Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. , 1995, Journal of lipid research.

[22]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[23]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[24]  S. O’Rahilly,et al.  Depot-related gene expression in human subcutaneous and omental adipocytes. , 1998, Diabetes.

[25]  G. Fey,et al.  Human complement component C3: cDNA coding sequence and derived primary structure. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Weigle Ds.  Leptin and other secretory products of adipocytes modulate multiple physiological functions. , 1997 .

[27]  P. Björntorp.  Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.

[28]  L. Sjöström,et al.  Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. , 1998, The Journal of clinical endocrinology and metabolism.

[29]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[30]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[31]  P. Arner,et al.  Regional differences in the control of lipolysis in human adipose tissue. , 1979, Metabolism: clinical and experimental.

[32]  J. Flier,et al.  The adipocyte: Storage depot or node on the energy information superhighway? , 1995, Cell.

[33]  D. Auboeuf,et al.  The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. , 1997, Analytical biochemistry.

[34]  C. Darimont,et al.  Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. , 1994, Endocrinology.

[35]  H. Kahn,et al.  A Review of the Association between Abdominal Fat Distribution, Health Outcome Measures, and Modifiable Risk Factors , 1993, American journal of health promotion : AJHP.

[36]  M. Saraste,et al.  FEBS Lett , 2000 .